Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-02-05 @ 3:03 PM
Study NCT ID:
NCT04643795
Status:
COMPLETED
Last Update Posted:
2023-10-05
First Post:
2020-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects
Sponsor:
Madrigal Pharmaceuticals, Inc.
Organization: